The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antiviral Therapy Market Research Report 2025
Synopsis
Antiviral therapy is one of the most exciting branches of virology. It entails several strategies used to develop antiviral therapy, including direct-acting antivirals that target viral proteins, enzymes, or nucleic acids; passive antibodies that neutralize viruses circulating in drug; and drugs that target cellular proteins or processes essential for viral replication.
The global Antiviral Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antiviral Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiviral Therapy.
Report Scope
The Antiviral Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antiviral Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiviral Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie Inc.
Abbott
F. Hoffmann-La Roche Ltd
Bristol-Myers Squibb Company
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Gilead Sciences, Inc.
GlaxoSmithKline plc
Aurobindo Pharma
AstraZeneca
Segment by Type
Generic Drugs
Branded Drugs
Segment by Application
HIV
Hepatitis
Herpes
Virus Influenza
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiviral Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Antiviral therapy is one of the most exciting branches of virology. It entails several strategies used to develop antiviral therapy, including direct-acting antivirals that target viral proteins, enzymes, or nucleic acids; passive antibodies that neutralize viruses circulating in drug; and drugs that target cellular proteins or processes essential for viral replication.
The global Antiviral Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antiviral Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiviral Therapy.
Report Scope
The Antiviral Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antiviral Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiviral Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie Inc.
Abbott
F. Hoffmann-La Roche Ltd
Bristol-Myers Squibb Company
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Gilead Sciences, Inc.
GlaxoSmithKline plc
Aurobindo Pharma
AstraZeneca
Segment by Type
Generic Drugs
Branded Drugs
Segment by Application
HIV
Hepatitis
Herpes
Virus Influenza
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiviral Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiviral Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Generic Drugs
1.2.3 Branded Drugs
1.3 Market by Application
1.3.1 Global Antiviral Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 HIV
1.3.3 Hepatitis
1.3.4 Herpes
1.3.5 Virus Influenza
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiviral Therapy Market Perspective (2019-2030)
2.2 Antiviral Therapy Growth Trends by Region
2.2.1 Global Antiviral Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antiviral Therapy Historic Market Size by Region (2019-2024)
2.2.3 Antiviral Therapy Forecasted Market Size by Region (2025-2030)
2.3 Antiviral Therapy Market Dynamics
2.3.1 Antiviral Therapy Industry Trends
2.3.2 Antiviral Therapy Market Drivers
2.3.3 Antiviral Therapy Market Challenges
2.3.4 Antiviral Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiviral Therapy Players by Revenue
3.1.1 Global Top Antiviral Therapy Players by Revenue (2019-2024)
3.1.2 Global Antiviral Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Antiviral Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antiviral Therapy Revenue
3.4 Global Antiviral Therapy Market Concentration Ratio
3.4.1 Global Antiviral Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiviral Therapy Revenue in 2023
3.5 Antiviral Therapy Key Players Head office and Area Served
3.6 Key Players Antiviral Therapy Product Solution and Service
3.7 Date of Enter into Antiviral Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiviral Therapy Breakdown Data by Type
4.1 Global Antiviral Therapy Historic Market Size by Type (2019-2024)
4.2 Global Antiviral Therapy Forecasted Market Size by Type (2025-2030)
5 Antiviral Therapy Breakdown Data by Application
5.1 Global Antiviral Therapy Historic Market Size by Application (2019-2024)
5.2 Global Antiviral Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antiviral Therapy Market Size (2019-2030)
6.2 North America Antiviral Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antiviral Therapy Market Size by Country (2019-2024)
6.4 North America Antiviral Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiviral Therapy Market Size (2019-2030)
7.2 Europe Antiviral Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antiviral Therapy Market Size by Country (2019-2024)
7.4 Europe Antiviral Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiviral Therapy Market Size (2019-2030)
8.2 Asia-Pacific Antiviral Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antiviral Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Antiviral Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antiviral Therapy Market Size (2019-2030)
9.2 Latin America Antiviral Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antiviral Therapy Market Size by Country (2019-2024)
9.4 Latin America Antiviral Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiviral Therapy Market Size (2019-2030)
10.2 Middle East & Africa Antiviral Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antiviral Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Antiviral Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Company Detail
11.1.2 AbbVie Inc. Business Overview
11.1.3 AbbVie Inc. Antiviral Therapy Introduction
11.1.4 AbbVie Inc. Revenue in Antiviral Therapy Business (2019-2024)
11.1.5 AbbVie Inc. Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Antiviral Therapy Introduction
11.2.4 Abbott Revenue in Antiviral Therapy Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Detail
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Antiviral Therapy Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Antiviral Therapy Business (2019-2024)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Company Detail
11.4.2 Bristol-Myers Squibb Company Business Overview
11.4.3 Bristol-Myers Squibb Company Antiviral Therapy Introduction
11.4.4 Bristol-Myers Squibb Company Revenue in Antiviral Therapy Business (2019-2024)
11.4.5 Bristol-Myers Squibb Company Recent Development
11.5 Johnson & Johnson Services, Inc.
11.5.1 Johnson & Johnson Services, Inc. Company Detail
11.5.2 Johnson & Johnson Services, Inc. Business Overview
11.5.3 Johnson & Johnson Services, Inc. Antiviral Therapy Introduction
11.5.4 Johnson & Johnson Services, Inc. Revenue in Antiviral Therapy Business (2019-2024)
11.5.5 Johnson & Johnson Services, Inc. Recent Development
11.6 Merck & Co., Inc.
11.6.1 Merck & Co., Inc. Company Detail
11.6.2 Merck & Co., Inc. Business Overview
11.6.3 Merck & Co., Inc. Antiviral Therapy Introduction
11.6.4 Merck & Co., Inc. Revenue in Antiviral Therapy Business (2019-2024)
11.6.5 Merck & Co., Inc. Recent Development
11.7 Gilead Sciences, Inc.
11.7.1 Gilead Sciences, Inc. Company Detail
11.7.2 Gilead Sciences, Inc. Business Overview
11.7.3 Gilead Sciences, Inc. Antiviral Therapy Introduction
11.7.4 Gilead Sciences, Inc. Revenue in Antiviral Therapy Business (2019-2024)
11.7.5 Gilead Sciences, Inc. Recent Development
11.8 GlaxoSmithKline plc
11.8.1 GlaxoSmithKline plc Company Detail
11.8.2 GlaxoSmithKline plc Business Overview
11.8.3 GlaxoSmithKline plc Antiviral Therapy Introduction
11.8.4 GlaxoSmithKline plc Revenue in Antiviral Therapy Business (2019-2024)
11.8.5 GlaxoSmithKline plc Recent Development
11.9 Aurobindo Pharma
11.9.1 Aurobindo Pharma Company Detail
11.9.2 Aurobindo Pharma Business Overview
11.9.3 Aurobindo Pharma Antiviral Therapy Introduction
11.9.4 Aurobindo Pharma Revenue in Antiviral Therapy Business (2019-2024)
11.9.5 Aurobindo Pharma Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Detail
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Antiviral Therapy Introduction
11.10.4 AstraZeneca Revenue in Antiviral Therapy Business (2019-2024)
11.10.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Antiviral Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Generic Drugs
Table 3. Key Players of Branded Drugs
Table 4. Global Antiviral Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Antiviral Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Antiviral Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Antiviral Therapy Market Share by Region (2019-2024)
Table 8. Global Antiviral Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Antiviral Therapy Market Share by Region (2025-2030)
Table 10. Antiviral Therapy Market Trends
Table 11. Antiviral Therapy Market Drivers
Table 12. Antiviral Therapy Market Challenges
Table 13. Antiviral Therapy Market Restraints
Table 14. Global Antiviral Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Antiviral Therapy Market Share by Players (2019-2024)
Table 16. Global Top Antiviral Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Therapy as of 2023)
Table 17. Ranking of Global Top Antiviral Therapy Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Antiviral Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Antiviral Therapy Product Solution and Service
Table 21. Date of Enter into Antiviral Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antiviral Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Antiviral Therapy Revenue Market Share by Type (2019-2024)
Table 25. Global Antiviral Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Antiviral Therapy Revenue Market Share by Type (2025-2030)
Table 27. Global Antiviral Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Antiviral Therapy Revenue Market Share by Application (2019-2024)
Table 29. Global Antiviral Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Antiviral Therapy Revenue Market Share by Application (2025-2030)
Table 31. North America Antiviral Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Antiviral Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Antiviral Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Antiviral Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Antiviral Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Antiviral Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Antiviral Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Antiviral Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Antiviral Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Antiviral Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Antiviral Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Antiviral Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Antiviral Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Antiviral Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Antiviral Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. AbbVie Inc. Company Detail
Table 47. AbbVie Inc. Business Overview
Table 48. AbbVie Inc. Antiviral Therapy Product
Table 49. AbbVie Inc. Revenue in Antiviral Therapy Business (2019-2024) & (US$ Million)
Table 50. AbbVie Inc. Recent Development
Table 51. Abbott Company Detail
Table 52. Abbott Business Overview
Table 53. Abbott Antiviral Therapy Product
Table 54. Abbott Revenue in Antiviral Therapy Business (2019-2024) & (US$ Million)
Table 55. Abbott Recent Development
Table 56. F. Hoffmann-La Roche Ltd Company Detail
Table 57. F. Hoffmann-La Roche Ltd Business Overview
Table 58. F. Hoffmann-La Roche Ltd Antiviral Therapy Product
Table 59. F. Hoffmann-La Roche Ltd Revenue in Antiviral Therapy Business (2019-2024) & (US$ Million)
Table 60. F. Hoffmann-La Roche Ltd Recent Development
Table 61. Bristol-Myers Squibb Company Company Detail
Table 62. Bristol-Myers Squibb Company Business Overview
Table 63. Bristol-Myers Squibb Company Antiviral Therapy Product
Table 64. Bristol-Myers Squibb Company Revenue in Antiviral Therapy Business (2019-2024) & (US$ Million)
Table 65. Bristol-Myers Squibb Company Recent Development
Table 66. Johnson & Johnson Services, Inc. Company Detail
Table 67. Johnson & Johnson Services, Inc. Business Overview
Table 68. Johnson & Johnson Services, Inc. Antiviral Therapy Product
Table 69. Johnson & Johnson Services, Inc. Revenue in Antiviral Therapy Business (2019-2024) & (US$ Million)
Table 70. Johnson & Johnson Services, Inc. Recent Development
Table 71. Merck & Co., Inc. Company Detail
Table 72. Merck & Co., Inc. Business Overview
Table 73. Merck & Co., Inc. Antiviral Therapy Product
Table 74. Merck & Co., Inc. Revenue in Antiviral Therapy Business (2019-2024) & (US$ Million)
Table 75. Merck & Co., Inc. Recent Development
Table 76. Gilead Sciences, Inc. Company Detail
Table 77. Gilead Sciences, Inc. Business Overview
Table 78. Gilead Sciences, Inc. Antiviral Therapy Product
Table 79. Gilead Sciences, Inc. Revenue in Antiviral Therapy Business (2019-2024) & (US$ Million)
Table 80. Gilead Sciences, Inc. Recent Development
Table 81. GlaxoSmithKline plc Company Detail
Table 82. GlaxoSmithKline plc Business Overview
Table 83. GlaxoSmithKline plc Antiviral Therapy Product
Table 84. GlaxoSmithKline plc Revenue in Antiviral Therapy Business (2019-2024) & (US$ Million)
Table 85. GlaxoSmithKline plc Recent Development
Table 86. Aurobindo Pharma Company Detail
Table 87. Aurobindo Pharma Business Overview
Table 88. Aurobindo Pharma Antiviral Therapy Product
Table 89. Aurobindo Pharma Revenue in Antiviral Therapy Business (2019-2024) & (US$ Million)
Table 90. Aurobindo Pharma Recent Development
Table 91. AstraZeneca Company Detail
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Antiviral Therapy Product
Table 94. AstraZeneca Revenue in Antiviral Therapy Business (2019-2024) & (US$ Million)
Table 95. AstraZeneca Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiviral Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Antiviral Therapy Market Share by Type: 2023 VS 2030
Figure 3. Generic Drugs Features
Figure 4. Branded Drugs Features
Figure 5. Global Antiviral Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Antiviral Therapy Market Share by Application: 2023 VS 2030
Figure 7. HIV Case Studies
Figure 8. Hepatitis Case Studies
Figure 9. Herpes Case Studies
Figure 10. Virus Influenza Case Studies
Figure 11. Others Case Studies
Figure 12. Antiviral Therapy Report Years Considered
Figure 13. Global Antiviral Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Antiviral Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Antiviral Therapy Market Share by Region: 2023 VS 2030
Figure 16. Global Antiviral Therapy Market Share by Players in 2023
Figure 17. Global Top Antiviral Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Therapy as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Antiviral Therapy Revenue in 2023
Figure 19. North America Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Antiviral Therapy Market Share by Country (2019-2030)
Figure 21. United States Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Antiviral Therapy Market Share by Country (2019-2030)
Figure 25. Germany Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Antiviral Therapy Market Share by Region (2019-2030)
Figure 33. China Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Antiviral Therapy Market Share by Country (2019-2030)
Figure 41. Mexico Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Antiviral Therapy Market Share by Country (2019-2030)
Figure 45. Turkey Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Antiviral Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. AbbVie Inc. Revenue Growth Rate in Antiviral Therapy Business (2019-2024)
Figure 48. Abbott Revenue Growth Rate in Antiviral Therapy Business (2019-2024)
Figure 49. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Antiviral Therapy Business (2019-2024)
Figure 50. Bristol-Myers Squibb Company Revenue Growth Rate in Antiviral Therapy Business (2019-2024)
Figure 51. Johnson & Johnson Services, Inc. Revenue Growth Rate in Antiviral Therapy Business (2019-2024)
Figure 52. Merck & Co., Inc. Revenue Growth Rate in Antiviral Therapy Business (2019-2024)
Figure 53. Gilead Sciences, Inc. Revenue Growth Rate in Antiviral Therapy Business (2019-2024)
Figure 54. GlaxoSmithKline plc Revenue Growth Rate in Antiviral Therapy Business (2019-2024)
Figure 55. Aurobindo Pharma Revenue Growth Rate in Antiviral Therapy Business (2019-2024)
Figure 56. AstraZeneca Revenue Growth Rate in Antiviral Therapy Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
